[ad_1]
6:49 pm
Wednesday 11 November 2020
Books – Muhammad Ghayat:
Dr Mostafa Madbouly, Prime Minister, chaired the medical committee meeting today, to discuss developments in the announcement by several international companies that they had achieved breakthrough results in coronavirus vaccines, and discussed ways to ensure Egypt had the adequate doses of these vaccines.
The meeting was attended by Dr. Khaled Abdel Ghaffar, Minister of Higher Education and Scientific Research, Dr. Mohamed Maait, Minister of Finance, Dr. Hala Zayed, Minister of Health and Population, Dr. Muhammad Awad Tajuddin, Advisor to the President of the Republic for Health and Prevention Affairs, and Major General Bahaa El Din Zidan, President of the Egyptian Purchasing Authority. Consolidated Medical Supplies and Supplies Department, Department of Medical Technology and Dr. Tamer Essam, President of the Egyptian Medicines Authority.
The Prime Minister affirmed the government’s interest in holding this meeting; To discuss vaccine dossier developments that have been announced, so Egypt can act sooner. Ensure sufficient doses of these vaccines, which will achieve the approval and approval of the World Health Organization.
The Minister of Health and Population spoke about the position of the “Pfizer” vaccine, which depends on the use of mRN technology. The company announced that the vaccine had been tested on 30,000 volunteers in the United States, Argentina, Brazil and Germany. Subsequently, the companies reported that the volunteers suffered after receiving them. The first dose has mild to moderate side effects.
Dr. Hala Zayed also noted that the two companies that produce vaccines were later announced that they would make an effort; To broaden its experience in the United States to include 43 thousand participants, and in fact the two companies obtained permission to begin testing the vaccine in children as young as 12 years old, and on November 8, promising results were achieved after analyzing the results of the first 94 cases of Covid-19 in the experiment, noting that currently, Pfizer is expected to apply for an emergency use permit.
The Minister of Health said: It is necessary to define the objectives of the vaccination strategy, and consequently the population groups are ordered according to the priority of obtaining limited supplies of the vaccine in the first phase of its availability, in accordance with the guidelines of the World Health Organization, and the organization also suggested, according to the Minister, that countries give priority to populations at risk, first providing them with available vaccines and then providing them to other population groups.
At the conclusion of the meeting, the agreement reached with the International Alliance for Vaccines and Vaccines (GAVI) was noted that Egypt would obtain 20 million doses of vaccines that will achieve emergency approval from the World Health Organization, provided that give specific priority, which includes the most vulnerable people. By the virus, such as medical personnel, and the most affected people, such as people with chronic diseases and the elderly.
